SBRT
Clinical trials for SBRT explained in plain language.
Never miss a new study
Get alerted when new SBRT trials appear
Sign up with your email to follow new studies for SBRT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy aims to control liver cancer after first treatment fails
Disease control Not yet recruitingThis study tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few spots and stopped responding to initial therapy. The goal is to see if this triple approach can slow or stop cancer gro…
Matched conditions: SBRT
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New combo therapy targets Hard-to-Treat salivary gland tumors
Disease control Not yet recruitingThis study tests a two-step treatment for people with salivary gland cancer that has come back or spread. First, patients get an antibody-drug conjugate (ADC) that delivers chemotherapy directly to cancer cells. If the disease stabilizes or only a few new spots appear, they also …
Matched conditions: SBRT
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated May 26, 2026 04:36 UTC